contract « Science and Enterprise

In one of its first actions, the Biden administration rejoined the United States in the World Health Organization,… https://t.co/gpHTTr70DP
about 12 hours ago
New post on Science and Enterprise: U.S. Rejoins WHO, Participates in Int’l Vaccine Project https://t.co/bBUZr5UzSg #Science #Business
about 12 hours ago
A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower ris… https://t.co/EPYrP8wElE
about 17 hours ago
New post on Science and Enterprise: Antibodies Prevent Covid-19 Symptoms in Long-Term Care https://t.co/sePqojZMVd #Science #Business
about 17 hours ago
Another way to connect 100 million people end-to-end with Covid-19 vaccines. https://t.co/wIWk0XNDhv
about 1 day ago

US Govt to Buy 1.25M Regeneron Covid-19 Therapies

By Alan, on January 13th, 2021%

The U.S. Department of Health and Human Services is buying up to 1.25 million more doses of Regeneron’s Covid-19 antibody therapy, for $2.63 billion. . . . → Read More: US Govt to Buy 1.25M Regeneron Covid-19 Therapies

BARDA Funding Vaccine Patch Clinical Trial

By Alan, on October 5th, 2020%

The U.S. government’s medical preparedness agency is funding a clinical trial of a patch that dispenses vaccines with a much lower dose than syringes. . . . → Read More: BARDA Funding Vaccine Patch Clinical Trial

Group Advancing Electronic Spinal Cord Injury Therapies

By Alan, on October 1st, 2020%

A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries. . . . → Read More: Group Advancing Electronic Spinal Cord Injury Therapies

DoD Funding Variable Covid-19 Vaccine Technology

By Alan, on August 20th, 2020%

The U.S. Department of Defense is funding work on a Covid-19 vaccine platform that can adjust its formula to protect against future mutations in the virus. . . . → Read More: DoD Funding Variable Covid-19 Vaccine Technology

NIH Issues Contracts for Faster Covid-19 Diagnostics

By Alan, on July 31st, 2020%

National Institutes of Health awarded contracts to seven companies for higher-speed Covid-19 detection tests to ease current reporting delays. . . . → Read More: NIH Issues Contracts for Faster Covid-19 Diagnostics

BARDA to Buy $2B in Covid-19 Vaccines, Therapies

By Alan, on July 7th, 2020%

The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines and treatments now in clinical trials. . . . → Read More: BARDA to Buy $2B in Covid-19 Vaccines, Therapies

Fast Covid-19 Antibody Test Gets BARDA Funds

By Alan, on June 23rd, 2020%

A company developing point-of-care diagnostics is receiving a federal government contract for a one-drop blood test that detects Covid-19 virus antibodies in five minutes. . . . → Read More: Fast Covid-19 Antibody Test Gets BARDA Funds

Covid-19 Antibody Therapy Prepares for Trial

By Alan, on April 16th, 2020%

A biotechnology company producing synthetic antibodies in cattle, without human blood, to treat Covid-19 infections is advancing the therapy toward a clinical trial. . . . → Read More: Covid-19 Antibody Therapy Prepares for Trial

Retina Implant, Stem Cell Studies Set for Space Station

By Alan, on April 9th, 2020%

A company providing laboratory modules for biomedical research on the International Space Station received funding from NASA for three new projects. . . . → Read More: Retina Implant, Stem Cell Studies Set for Space Station

Synthetic DNA Studied for Mass Data Storage

By Alan, on January 16th, 2020%

An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals like DNA for reliably storing massive amounts of data. . . . → Read More: Synthetic DNA Studied for Mass Data Storage

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise